Table 1. Incubation period, duration of hospitalization, and time from onset to medical visit, hospitalization, and laboratory diagnosis of COVID-19.
| Authors | Location/Population | Period of Study | Case Numbers | Estimates (days) | Variation |
|---|---|---|---|---|---|
| Incubation Period | |||||
| Li and colleagues [21] | Wuhan | Before Jan 21 | 10 | 5.2a | 95% CI 4.1–7.0 |
| Xu and colleagues [22] | Zhejiang | Jan 10–26 | 56 | 4.0b | IQR 3.0–5.0 |
| Backer and colleagues [23] | Travelers from Wuhan | Jan 20–28 | 88 | 6.4a | 95% CI 5.6–7.7 |
| Guan and colleagues [24] | China | Dec 11–Jan 29 | 291 | 4.0b | IQR 2.0–7.0 |
| Linton and colleagues [25] | China, publicly available | Before Jan 31 | 158 | 5.6c | 95% CI 5.0–6.3 |
| Tian and colleagues [26] | Beijing | Before Feb 10 | 262 | 6.7 | SD 5.2 |
| Bi e and colleagues [27] | Shenzhen | Jan 14–Feb 12 | 183 | 4.8b,d | 95% CI 4.2–5.4 |
| Wang and colleagues [28] | Henan | Jan 21–Feb 14 | 483 | 7.4d | 95% CI 2.0–20.0 |
| WHO [6] | China | Before Feb 20 | NA | 5.0–6.0 | Range 1–14 |
| Onset to first medical visit | |||||
| Li and colleagues [21] | Wuhan | Before Jan 1 | 45 | 5.8a | 95% CI 4.3–7.5 |
| Li and colleagues [21] | Wuhan | Jan 1–11 | 207 | 4.6a | 95% CI 4.1–5.1 |
| Sun and colleagues [29] | China, publicly available | Before Jan 18 | NA | 5.0b | NA |
| Sun and colleagues [29] | China, publicly available | After Jan 18 | NA | 2.0b | NA |
| Sun and colleagues [29] | China, publicly available | Jan 22–30 | 200 | 3.0b | IQR 0.0–15.0 |
| W u and colleagues [30] | Tianjin | Before Feb 18 | 40 | 4.5b | Range 1.0–13.0 |
| Onset to hospitalization | |||||
| Huang and colleagues [14] | Wuhan | Dec 16–Jan 1 | 41 | 7.0b | IQR 4.0–8.0 |
| Li and colleagues [21] | Wuhan | Before Jan 1 | 44 | 12.5a | 95% CI 10.3–14.8 |
| Li and colleagues [21] | Wuhan | Jan 1–11 | 189 | 9.1a | 95% CI 8.6–9.7 |
| Xu and colleagues [22] | Zhejiang | Jan 10–26 | 62 | 2.0b | IQR 1.0–4.3 |
| Wang and colleagues [31] | Wuhan | Jan 1–28 | 138 | 7.0b | IQR 4.0–8.0 |
| Linton and colleagues [25] | Outside of Wuhan, living | Before Jan 31 | 155 | 3.3b,c | 95% CI 2.7–4.0 |
| Linton and colleagues [25] | Outside of Wuhan, deceased | Before Jan 31 | 34 | 6.5b,c | 95% CI 5.2–8.0 |
| Tian and colleagues [26] | Beijing | Before Feb 10 | 262 | 4.5 | SD 3.7 |
| Onset to laboratory diagnosis | |||||
| WHO [6] | China | early Jan | NA | 12.0b | Range 8.0–18.0 |
| WHO [6] | China | early Feb | NA | 3.0b | Range 1.0–7.0 |
| WHO [6] | Wuhan | early Jan | NA | 15.0b | Range 10.0–21.0 |
| WHO [6] | Wuhan | early Feb | NA | 5.0b | Range 3.0–9.0 |
| Bi and colleagues [27] | Shenzhen | Jan 14–Feb 12 | 183 | 5.5 | 95% CI 5.0–5.9 |
| Hospitalization to laboratory diagnosis | |||||
| Tian and colleagues [26] | Beijing | Before Feb 10 | 262 | 2.1 | SD 1.9 |
| Onset to dyspnea | |||||
| Huang and colleagues [14] | Wuhan | Dec 16–Jan 2 | 41 | 8.0b | 95% CI 5.0–13.0 |
| Wang and colleagues [31] | Wuhan | Jan 1–28 | 138 | 5.0b | IQR 1.0–10.0 |
| Onset to ICU admission | |||||
| Wang and colleagues [31] | Wuhan | Jan 1–28 | 36 | 10.0 | IQR 6.0–12.0 |
| Zhou and colleagues [32] | Wuhan, ≥18 years old | Before Jan 31 | 191 | 12.0b | IQR 8.0–15.0 |
| Onset to clinical recovery | |||||
| WHO [6] | China, mild cases | Before Feb 20 | NA | NA | 2.0 weeks |
| WHO [6] | China, severe cases | Before Feb 20 | NA | NA | 3.0–6.0 weeks |
| Onset to death | |||||
| Wang and colleagues [30] | China | Dec 1–Jan 26 | 17 | 14.0b | Range 6.0–41.0 |
| Wang and colleagues [30] | China, 70 years old or above | Dec–Jan 26 | NA | 11.5 | Range 6.0–19.0 |
| Wang and colleagues [30] | China, below 70 years old | Dec 1–Jan 26 | NA | 20.0 | Range 10.0–41.0 |
| Linton and colleagues [25] | China, publicly available | Before Jan 31 | 158 | 15.0d | 95% CI 12.8–17.5 |
| WHO [6] | China | Before Feb 20 | 2,114 | NA | Range 2.0–8.0 weeks |
| Zhou and colleagues [32] | Wuhan, ≥18 years old | Before Jan 31 | 54 | 18.5b | IQR 15.0–22.0 |
| Hospitalization to death | |||||
| Linton and colleagues [25] | China, publicly available | Before Jan 31 | 16 | 8.8a | 95% CI 7.2–10.8 |
| Zhou and colleagues [32] | Wuhan, ≥18 years old | Before Jan 31 | 54 | 7.5b | IQR 5.0–11.0 |
| Hospitalization to discharge | |||||
| Guan and colleagues [24] | China | Dec 11–Jan 29 | 963 | 12.0 | IQR 10.0–14.0 |
| Zhou and colleagues [32] | Wuhan, ≥18 years old | Before Jan 31 | 137 | 12.0b | IQR 9.0–15.0 |
| Wu and colleagues [33] | Wuhan | Dec 25–Feb 13 | 201 | 13.0b | IQR 10.0–16.0 |
Abbreviations: COVID-19, coronavirus disease 19; ICU, intensive care unit; IQR, interquartile range; NA, not reported in the paper; 95% CI, 95% confidence interval.
aWeibull distribution was used to estimate means and 95% CI.
bThe estimates are medians, the rest are means.
cGamma distribution was used to estimate median and 95% credible interval.
dLog-normal distribution was used to estimate median and 95% credible interval.